ACR were logarithmically transformed to improve normality. A P-value <0.05 was considered statistically significant.
We studied a total of 269 type 2 diabetic patients with clinical albuminuria, 71 women and 198 men, with a mean (AESD) age of 61 AE 12 years. Mean serum creatinine was 1.91 AE 1.42 mg/dl (range: 0.38-10.15) and blood haemoglobin was 11.9 AE 2.0 g/dl (8.0-17.3) . Geometric mean eGFR, urinary ACR and serum EPO were 31.5 ml/min/1.73 m 2 (4.6-100.3), 1400.3 mg/g Cr (300-11 213.9), and 21.9 mU/ml (8.8-85.3) . Among 269 patients, 81 patients were treated with an angiotensin-converting enzyme (ACE) inhibitor, 140 with an angiotensin receptor blocker (ARB), 150 with a diuretic and 55 with other antihypertensives.
In univariate correlational analyses, serum EPO correlated positively with age (R s ¼ 0.204, P < 0.001) and inversely with ACR (R s ¼ À0.188, P ¼ 0.002). There was no significant correlation between serum EPO and eGFR (R s ¼ 0.107, P ¼ 0.080) or blood haemoglobin (R s ¼ 0.052, P ¼ 0.398). In the multiple regression analysis, age and logarithmic ACR remained in the model as variables significantly associated with logarithmic serum EPO, with the standardized partial regression coefficient of 0.198 (P ¼ 0.002) for age and À0.127 (P ¼ 0.049) for logarithmic ACR; the association between logarithmic eGFR and serum EPO was marginal (standardized partial regression coefficient: 0.109, P ¼ 0.087). Urinary EPO was undectable in 75% of patients. There was no significant correlation between urinary EPO and ACR (R s ¼ 0.0143, P ¼ 0.834).
In this cross-sectional study, we demonstrate for the first time that lower serum EPO levels was independently associated with increased albuminuria but not with reduced GFR in diabetic patients. In glomerular diseases, increased protein filtration through the glomeruli, including filtration of cytotoxic cytokines, causes tubulointerstitial injury. We hypothesize that glomerular-proteinuria-induced tubulointerstitial damage, and the consequent reduced number of EPOproducing peritubular fibroblasts, may be responsible for decreased serum EPO levels, irrespective of GFR levels.
Another possibility for the decreased EPO levels may be due to increased glomerular filtration of EPO [5] , which has a molecular weight of 30 400. Our present data do not support this hypothesis, as there was no relationship between urinary EPO and albuminuria, in accordance with an earlier study of children with nephrotic syndrome [6] . However, direct measurement of urinary EPO may be problematic due to conformational changes in EPO epitope following glomerular filtration.
In conclusion, we found that increased albuminuria was independently associated with decreased serum EPO levels in patients with type 2 diabetes regardless of GFR. Reduced EPO production of peritubular cells is most likely associated with lower EPO levels. Urinary loss of EPO should be determined by more sophisticated methods. Herein we report a deaf daughter of consanguineous parents, who was referred to our nephrology unit for the first time at the age of 20, because of refractory hypocalaemia. The patient was born by vaginal delivery, and although the mother had a large amount of amniotic fluid on ultrasound examination during pregnancy, the post-natal period was unremarkable until the 2nd year of life, when parents reported hearing loss and she was diagnosed with congenital bilateral sensorineural deafness. Thereafter the clinical history was unexceptional apart from poly dipsia and polyuria. The patient's height and weight reached, respectively, 165 cm (percentile range of 25-50) and 70 kg (percentile range of 50-75). Serum and urine biochemical data at admission are summarized in Table 1 . The association of hypocalaemic metabolic alkalosis and hearing impairment led us to consider the diagnosis of BS type IV. Plasma renin and aldosterone were abnormally high and subsequent evaluation detected hypercalciuria and nephrocalcinosis ( Figure 1A) . The patient was found to be homozygous for the BSND c.139G>A allele ( Figure 1B) , resulting in Gly to Arg at position 47 (p.G47R). The patient was prescribed 40 mEq/day of chloride potassium and 25 mg/day of spironolactone. Three months after diagnosis, serum potassium and creatinine were 3.5 mmol/l and 61.9 mmol/l, respectively. However, hypercalciuria persisted.
A late-onset presentation of a renal phenotype in BS type IV has been previously published [5] . Similar to our case, the patient was homozygous for the p.G47R allele, but a decreased glomerular filtration rate (GFR) and unexplained bilateral nephrocalcinosis, given the absence of hypercalciuria, were reported. The same mutation was also described, in homozygosity, in two additional Spanish kindreds, with affected individuals presenting polyhydramnios, premature birth and salt loss, although not as severe as usually reported for BS type IV [6] . Since the co-expression of p.G47R barttin and ClC-Ka resulted in a Cl À current reduction to the same extent as those observed for other missense mutations [2], we can hypothesize that this allele enables barttin to retain some residual function with ClC-Kb, therefore conditioning a milder phenotype. In addition, the better long-term GFR preservation possibly allows for the filtered calcium to be over-excreted leading to more persistent hypercalciuria, as demonstrated for the first time in our patient. 
